Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

Cite this paper

@article{Kochenderfer2013DonorderivedCT, title={Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.}, author={James N. Kochenderfer and Mark Edward Dudley and Robert Owens Carpenter and Sadik H. Kassim and Jeremy J Rose and William G. Telford and Frances T Hakim and David C Halverson and D. Fowler and Nancy M Hardy and Anthony R Mato and Dennis Durand Hickstein and Juan C. Gea-Banacloche and Steven Z Pavletic and Claude Sport{\'e}s and Irina Maric and Steven Alexander Feldman and Brenna G Hansen and Jennifer S Wilder and Bazetta Blacklock-Schuver and Bipulendu Jena and Michael R. Bishop and Ronald E Gress and S. Rosenberg}, journal={Blood}, year={2013}, volume={122 25}, pages={4129-39} }